TRACTOBAN
Home » Ethical Marketing » TRACTOBAN
ATOSIBAN
TRACTOBAN
7.5 mg/mL
Solution for Injection (IV)
Tocolytic
Formulation
Each ml contains:
Atosiban | 7.5 mcg |
Water for Injection U.S.P. | q.s. |
Indications:
• Atosiban is indicated to delay imminent pre-term birth in pregnant adult women with:
◦ Regular uterine contractions of at least 30 seconds duration at a rate of ≥ 4 per 30 minutes
◦ A cervical dilation of 1 to 3 cm (0-3 for nulliparas) and effacement of ≥ 50%
◦ A gestational age from 24 until 33 completed weeks
◦ A normal foetal heart rate
◦ Regular uterine contractions of at least 30 seconds duration at a rate of ≥ 4 per 30 minutes
◦ A cervical dilation of 1 to 3 cm (0-3 for nulliparas) and effacement of ≥ 50%
◦ A gestational age from 24 until 33 completed weeks
◦ A normal foetal heart rate
Dosage and Administration:
As prescribed by the physician.
Storage:
Store at temperatures between 2-8O C.
Keep out of reach of children
Availability:
1 mL net content in 2 mL USP Type I Clear Glass Vial in a monocarton.
5 mL net content in 5 mL USP Type I clear Glass Vial in a monocarton.
Medical Disclaimer:
Please consult your physician for personalized medical advice. Always seek the advice of a physician or other qualified healthcare provider with any questions regarding a medical condition or treatment before undertaking a new healthcare regimen. This product brief is not an advertisement and is not intended to be a substitute for a professional medical advice, diagnosis, or treatment. Never disregard professional medical advice or delay in seeking it. If symptoms persist, consult your physician.